$AFL

Aflac Earnings Preview: What to Expect

Aflac (AFL) is scheduled to report Q2 earnings on Aug. 6, 2026 after the close. Analysts expect diluted EPS of $1.77 versus $1.78 a year ago. For fiscal 2026, consensus EPS is $7.07, down from $7.49 in 2025. AFL stock is up 21.9% over 52 weeks; consensus rating is Hold with an average target of $117.20.

Original reporting
Published Jul 22, 2026, 8:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 8:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Aflac Earnings Preview: What to Expect — source image
Decision brief

The 30-second read

$AFLNeutralLow
01

Why it matters

Traders can benchmark expectations against consensus EPS for Q2 ($1.77) and FY26 ($7.07) and position for potential upside/downside if results or commentary diverge.

02

Market read

This is an expectations-and-timing setup for the Aug. 6 earnings print, not a disclosure of new fundamentals.

03

What to watch

The preview does not discuss guidance details, investment income, or loss-ratio drivers, which are often the real swing factors for insurer earnings reactions.

Relevance 4/10Novelty 4/10Timing: ahead of Aug. 6 after-close Q2 earnings release

Background

Aflac is a supplemental health and life insurer with operations in the U.S. and Japan, and it is scheduled to report Q2 earnings after the close on Aug. 6, 2026.

Company-level read

Ticker impact

$AFLNeutralMedium confidence
Context

Article previews Aflac’s Q2 earnings on Aug. 6 and cites consensus EPS $1.77 and FY26 EPS $7.07 expectations.

Expected impact

Near-term volatility risk around the Aug. 6 after-close release versus the $1.77 EPS and FY26 $7.07 consensus.

Evidence & confidence

The piece provides specific consensus EPS levels and timing, but it does not disclose any new company-specific development beyond expectations.

Market effects

Limited read-across for insurers; this is primarily a single-name earnings setup with no new sector datapoint.

Minimal, as the article does not introduce new regional macro or regulatory developments.

Low, despite Japan operations mention, because no new Japan-specific catalyst is provided.

Counterpoint

If Aflac’s steady cash generation and buybacks continue to support results, the stock could outperform even with a modest EPS decline versus the year-ago quarter.

Key entities

  • Aflac Incorporated

    Subject of the earnings preview, scheduled to report Q2 earnings on Aug. 6, 2026.

Related articles

$AFLMed

Aflac: Q2 Earnings Snapshot

Aflac Inc. (AFL) reported Q2 net income of $825 million, or $1.63 per share. Adjusted earnings were $1.75 per share, below Zacks’ average estimate of $1.77. Revenue was $4.12 billion, with adjusted revenue of $4.22 billion versus $4.19 billion expected. Shares closed at $126.23.

$AFLLow

AFLAC INC (AFL): Results of Operations and Financial Condition

AFLAC INC (AFL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 afl063026-financialsupplem.htm EX-99.2 Document Final 08/06/2026 Financial Supplement Second Quarter 2026 This document is a statistical supplement to Aflac’s quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you

$TRVMed

Three 'Dividend Aristocrats' on Josh Brown's list in July's hottest sector

CNBC Pro’s Josh Brown and Sean Russo highlight three insurance “Dividend Aristocrats”: Travelers (TRV), Chubb (CB), and Aflac (AFL). Travelers reported Q2 core EPS $10.04 vs ~$5.39 consensus, with $2.2B income and AI-linked claims improvements; shares rose ~8%. Chubb and Aflac are noted for long dividend growth streaks and recent operating updates.

$AFLMed

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

The article discusses AI’s potential economic impact, citing Elon Musk’s prediction of 10 billion humanoid robots by 2040 and a $250 trillion value estimate. It also claims Morgan Stanley raised its Aflac (AFL) price target to $125, and promotes newsletter subscriptions tied to an “underdog” stock priced around $3, alleging $100 million in waste cuts and “400% upside.”

$AFLMedAI 8/10

Morgan Stanley Lifts Aflac (AFL) PT to $125 on Solid Insurance Trends

Morgan Stanley raised its Aflac (AFL) price target to $125 from $120 and kept an Equal Weight rating, citing generally strong Q1 life insurance results, expected earnings momentum through 2026, steady international operations, and improving mortality trends. Separately, Piper Sandler cut its target to $125 from $130, citing Q1 earnings below estimates due to weaker Japan performance, though it noted improving Japan benefit ratios and strong distribution.